Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

RecruitingOBSERVATIONAL
Enrollment

908

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Nasopharyngeal Carcinoma
Interventions
DIAGNOSTIC_TEST

VCA-IgA, EBNA1-IgA, and EBV-DNA

Detect VCA-IgA, EBNA1-IgA, and EBV-DNA for all participants.

DIAGNOSTIC_TEST

EBV C Promoter Methylation Detection in nasopharyngeal swab samples

Detection of methylation status of Epstein-Barr virus C promoter in human nasopharyngeal swab samples

Trial Locations (5)

350014

RECRUITING

Fujian Cancer Hospital, Fuzhou

510060

RECRUITING

Sun Yat-Sen University Cancer Center, Guangzhou

528400

RECRUITING

ZhongShan City People's Hospital, Zhongshan

530021

RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

543002

RECRUITING

Wuzhou Red Cross Hospital, Wuzhou

All Listed Sponsors
collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Wuzhou Red Cross Hospital

OTHER

collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

collaborator

First Affiliated Hospital of Guangxi Medical University

OTHER

lead

Sun Yat-sen University

OTHER